PYRGF vs. BTMD, TIL, HURA, VIRI, CGTX, ONCY, SPRO, IKT, VTGN, and KLRS
Should you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include biote (BTMD), Instil Bio (TIL), TuHURA Biosciences (HURA), Virios Therapeutics (VIRI), Cognition Therapeutics (CGTX), Oncolytics Biotech (ONCY), Spero Therapeutics (SPRO), Inhibikase Therapeutics (IKT), VistaGen Therapeutics (VTGN), and Kalaris Therapeutics (KLRS). These companies are all part of the "pharmaceutical products" industry.
PyroGenesis Canada vs. Its Competitors
biote (NASDAQ:BTMD) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.
biote has a net margin of 15.73% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat biote's return on equity.
In the previous week, PyroGenesis Canada had 1 more articles in the media than biote. MarketBeat recorded 1 mentions for PyroGenesis Canada and 0 mentions for biote. biote's average media sentiment score of 0.70 beat PyroGenesis Canada's score of 0.00 indicating that biote is being referred to more favorably in the media.
biote has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, PyroGenesis Canada has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500.
21.7% of biote shares are owned by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are owned by institutional investors. 24.0% of biote shares are owned by insiders. Comparatively, 47.7% of PyroGenesis Canada shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
biote has higher revenue and earnings than PyroGenesis Canada. PyroGenesis Canada is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks.
biote presently has a consensus price target of $6.00, indicating a potential upside of 107.97%. Given biote's stronger consensus rating and higher possible upside, research analysts clearly believe biote is more favorable than PyroGenesis Canada.
Summary
biote beats PyroGenesis Canada on 12 of the 16 factors compared between the two stocks.
Get PyroGenesis Canada News Delivered to You Automatically
Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PYRGF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PYRGF vs. The Competition
PyroGenesis Canada Competitors List
Related Companies and Tools
This page (NASDAQ:PYRGF) was last updated on 10/17/2025 by MarketBeat.com Staff
